For patients with symptomatic prosthetic mitral valve dysfunction, the traditional standard of care has been repeat surgical mitral valve replacement unless the patient’s clinical risk precluded surgery. For patients at…
Abstract Patients in cardiogenic shock due to severe failure of a mitral bioprosthesis have extremely high risk for repeat standard cardiac surgery. This patient population may benefit the most form…
Abstract Coronary perforation is a rare but potentially lethal complication of percutaneous coronary intervention. Management of coronary perforations is mainly conditioned by the extension of coronary rupture and location of…
Abstract Background Reduced leaflet motion (RLM) of transcatheter aortic valves (TAV) is observed in up to 4% of cases with similar frequency in surgical valves, with an overall incidence that…
Highlights • The development of many chronic total obstruction (CTO) techniques together with the hardware advancements have led to the improvement of the success rate of CTO percutaneous coronary interventions…
Abstract Background/purpose Catheter-based renal sympathetic denervation (RDN) has been introduced to lower blood pressure (BP) and sympathetic activity in patients with uncontrolled hypertension with at best equivocal results. It has…
Abstract Background In the recent years percutaneous treatment of the left main stem (LM) has gained a precise role as a result of consistent scientific evidence vs. coronary artery bypass….
Percutaneous coronary interventions (PCI) in chronic total occlusions (CTOs) have undergone tremendous advancements in techniques and success rates over the past 15 years. Expert hybrid operators are now able to…
Abstract Aims To assess both epicardiac macrovascular as well as microvascular and tissue reperfusion following different intravenous preadmission antithrombotic strategies prior primary PCI in STEMI patients. Methods and results Consecutive…
Abstract Background/purpose Percutaneous coronary intervention (PCI) is the preferred strategy for treatment of saphenous vein graft (SVG) disease. However, there remains ongoing debate on whether drug-eluting stents (DES) or bare-metal…
